Equity Research, Broker Reports, and media content on ACTIVE BIOTECH AB

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about ACTIVE BIOTECH AB
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on ACTIVE BIOTECH AB. We currently have 0 research reports from 0 professional analysts.

Open
18.2
Volume
0.2m
Range
17.5/18.6
Market Cap
1,752,520,030m
52 Week
9.10/21.9
Date Source Announcement
18May17 13:30 GNW Annual Report 2016 Active Biotech AB (publ)
17May17 07:30 GNW Active Biotech: Notice of Annual General Meeting of Shareholders
27Apr17 07:30 GNW Active Biotech: Interim report January - March 2017
12Apr17 12:30 GNW Active Biotech: FDA grants Orphan Drug Designation for tasquinimod for the treatment of multiple myeloma
16Feb17 07:30 GNW Active Biotech AB Year-end report January - December 2016
09Jan17 12:00 GNW The European Patent Office grants patent for tasquinimod for treatment of multiple myeloma
30Dec16 07:30 GNW Number of shares and votes in Active Biotech
  • Frequency of research reports

     

  • Research reports on

    ACTIVE BIOTECH AB

  • Providers covering

    ACTIVE BIOTECH AB